NO20042732L - Krystallinsk venlafaksin-base og nye polymorfe former av venlafaksin-hydroklorid samt fremgangsmater for fremstilling derav - Google Patents
Krystallinsk venlafaksin-base og nye polymorfe former av venlafaksin-hydroklorid samt fremgangsmater for fremstilling deravInfo
- Publication number
- NO20042732L NO20042732L NO20042732A NO20042732A NO20042732L NO 20042732 L NO20042732 L NO 20042732L NO 20042732 A NO20042732 A NO 20042732A NO 20042732 A NO20042732 A NO 20042732A NO 20042732 L NO20042732 L NO 20042732L
- Authority
- NO
- Norway
- Prior art keywords
- venlafaxine
- processes
- preparation
- well
- polymorphic forms
- Prior art date
Links
- 229960004688 venlafaxine Drugs 0.000 title 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 title 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
- C07C217/70—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/000,428 US20020183553A1 (en) | 2000-10-19 | 2001-11-30 | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| PCT/US2002/037268 WO2003048082A2 (en) | 2001-11-30 | 2002-11-20 | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042732L true NO20042732L (no) | 2004-06-29 |
Family
ID=21691493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042732A NO20042732L (no) | 2001-11-30 | 2004-06-29 | Krystallinsk venlafaksin-base og nye polymorfe former av venlafaksin-hydroklorid samt fremgangsmater for fremstilling derav |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US20020183553A1 (no) |
| EP (1) | EP1474379A4 (no) |
| JP (1) | JP2005511668A (no) |
| KR (1) | KR20040068163A (no) |
| CN (2) | CN1617848A (no) |
| AU (1) | AU2002365874A1 (no) |
| CA (1) | CA2468728A1 (no) |
| HR (1) | HRP20040565A2 (no) |
| HU (1) | HUP0700037A2 (no) |
| IL (1) | IL162171A0 (no) |
| IS (1) | IS7289A (no) |
| MX (1) | MXPA04005193A (no) |
| NO (1) | NO20042732L (no) |
| PL (1) | PL374273A1 (no) |
| WO (1) | WO2003048082A2 (no) |
| ZA (1) | ZA200404080B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE01988460T1 (de) * | 2000-10-19 | 2004-04-22 | Teva Pharmaceutical Industries Ltd. | Kristalline venlafaxinbase und neue venlafaxin-hydrochlorid-modifikationen sowie verfahren zu deren herstellung |
| AU1234002A (en) * | 2000-10-31 | 2002-05-15 | Ciba Sc Holding Ag | Crystalline forms of venlafaxine hydrochloride |
| AU2002348266A1 (en) * | 2001-12-05 | 2003-06-23 | Wyeth | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof |
| UA77234C2 (en) * | 2001-12-05 | 2006-11-15 | Wyeth Corp | Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants) |
| US20030191347A1 (en) * | 2002-03-28 | 2003-10-09 | Rolf Keltjens | Venlafaxine base |
| DE10359154A1 (de) * | 2003-12-16 | 2005-07-28 | Krka Tovarna Zdravil, D.D. | Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I |
| CA2625832A1 (en) * | 2005-10-19 | 2007-04-26 | Vinod Kumar Kansal | Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride |
| PT1954669E (pt) * | 2005-12-01 | 2015-10-23 | Auspex Pharmaceuticals Inc | Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica |
| ES2693948T3 (es) * | 2007-03-15 | 2018-12-14 | Auspex Pharmaceuticals, Inc. | Fenetilamina sustituida con actividad serotoninérgica y/o norepinefrinérgica |
| CN101279926A (zh) * | 2008-05-22 | 2008-10-08 | 杭州盛美医药科技开发有限公司 | 盐酸文拉法辛晶型FormⅠ的制备方法 |
| CA2883641C (en) | 2012-09-18 | 2021-09-14 | Auspex Pharmaceuticals, Inc. | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| EP3578546A1 (en) | 2013-11-15 | 2019-12-11 | Akebia Therapeutics Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
| CN114767672A (zh) | 2015-03-06 | 2022-07-22 | 奥斯拜客斯制药有限公司 | 氘代丁苯那嗪或包含氘代丁苯那嗪的组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
| US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| US4611078A (en) * | 1983-10-26 | 1986-09-09 | American Home Products Corporation | Substituted phenylacetonitriles |
| US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| DE01988460T1 (de) * | 2000-10-19 | 2004-04-22 | Teva Pharmaceutical Industries Ltd. | Kristalline venlafaxinbase und neue venlafaxin-hydrochlorid-modifikationen sowie verfahren zu deren herstellung |
| AU1234002A (en) | 2000-10-31 | 2002-05-15 | Ciba Sc Holding Ag | Crystalline forms of venlafaxine hydrochloride |
| AU2001235970A1 (en) | 2000-12-07 | 2002-06-18 | Dr. Reddy's Research Foundation | Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation |
| EP1249447B1 (en) * | 2001-04-10 | 2008-10-22 | Alembic Limited | Intermediate for the production of 1-[2-dimethylamino-1-(4-methoxyphenyl)-ethyl]-cyclohexanol |
| AU2002348266A1 (en) * | 2001-12-05 | 2003-06-23 | Wyeth | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof |
| AU2002247945A1 (en) * | 2001-12-13 | 2003-06-23 | Cadila Healthcare Limited | Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof |
-
2001
- 2001-11-30 US US10/000,428 patent/US20020183553A1/en not_active Abandoned
-
2002
- 2002-11-20 IL IL16217102A patent/IL162171A0/xx unknown
- 2002-11-20 HU HU0700037A patent/HUP0700037A2/hu unknown
- 2002-11-20 MX MXPA04005193A patent/MXPA04005193A/es active IP Right Grant
- 2002-11-20 CA CA002468728A patent/CA2468728A1/en not_active Abandoned
- 2002-11-20 PL PL02374273A patent/PL374273A1/xx not_active Application Discontinuation
- 2002-11-20 WO PCT/US2002/037268 patent/WO2003048082A2/en not_active Ceased
- 2002-11-20 CN CNA028276485A patent/CN1617848A/zh active Pending
- 2002-11-20 CN CNA2007101970607A patent/CN101219962A/zh active Pending
- 2002-11-20 ZA ZA200404080A patent/ZA200404080B/en unknown
- 2002-11-20 EP EP02791279A patent/EP1474379A4/en not_active Withdrawn
- 2002-11-20 JP JP2003549277A patent/JP2005511668A/ja active Pending
- 2002-11-20 HR HR20040565A patent/HRP20040565A2/xx not_active Application Discontinuation
- 2002-11-20 AU AU2002365874A patent/AU2002365874A1/en not_active Abandoned
- 2002-11-20 KR KR10-2004-7008012A patent/KR20040068163A/ko not_active Ceased
-
2004
- 2004-05-27 IS IS7289A patent/IS7289A/is unknown
- 2004-06-08 US US10/863,958 patent/US20040220278A1/en not_active Abandoned
- 2004-06-29 NO NO20042732A patent/NO20042732L/no not_active Application Discontinuation
- 2004-10-07 US US10/961,337 patent/US6924393B2/en not_active Expired - Fee Related
-
2008
- 2008-03-13 US US12/075,875 patent/US20080167498A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2468728A1 (en) | 2003-06-12 |
| AU2002365874A1 (en) | 2003-06-17 |
| WO2003048082A3 (en) | 2004-08-26 |
| US20050049304A1 (en) | 2005-03-03 |
| EP1474379A2 (en) | 2004-11-10 |
| MXPA04005193A (es) | 2005-02-22 |
| KR20040068163A (ko) | 2004-07-30 |
| IL162171A0 (en) | 2005-11-20 |
| HRP20040565A2 (en) | 2005-08-31 |
| PL374273A1 (en) | 2005-10-03 |
| CN101219962A (zh) | 2008-07-16 |
| CN1617848A (zh) | 2005-05-18 |
| EP1474379A4 (en) | 2006-06-07 |
| US20020183553A1 (en) | 2002-12-05 |
| JP2005511668A (ja) | 2005-04-28 |
| US6924393B2 (en) | 2005-08-02 |
| WO2003048082A2 (en) | 2003-06-12 |
| US20040220278A1 (en) | 2004-11-04 |
| US20080167498A1 (en) | 2008-07-10 |
| IS7289A (is) | 2004-05-27 |
| HUP0700037A2 (en) | 2007-05-02 |
| ZA200404080B (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL196287A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof | |
| NO20040266L (no) | Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav | |
| DE60233133D1 (de) | Polymorphe formen von 1-ä4-(5-cyanoindol-3-yl)butylü-4-(2-carbamoylbenzofuran-5-yl) piperazin-hydrochlorid | |
| DE60234629D1 (de) | Formoteroltartrat verfahren und polymorph | |
| NO20042932L (no) | En ny polymorf form av sertralin-hydroklorid og preparater som inneholder denne, samt nye fremgangsmater for fremstilling av polymorfe former og en amorf form av sertralinhydroklorid | |
| NO20044138L (no) | Krystallinsk polymorf form av irinotekanhydroklorid | |
| IL175513A0 (en) | Polymorphic forms of tegaserod base and salts thereof | |
| NO20040292L (no) | Fremgangsmate for fremstilling av 4-aminodifenylamin | |
| IS7289A (is) | Kristallaður venlafaxínbasi og nýir fjölgervingarvenlafaxínhýdróklóríðs, aðferðir til að framleiðaþá | |
| ITMI20031333A0 (it) | Processo di preparazione di raloxifene cloridrato | |
| IL162255A0 (en) | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof | |
| IL172006A0 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| IL165689A0 (en) | Polymorphic form XVI of fexofenadine hydrochloride | |
| NO20040479L (no) | Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid. | |
| AU2003297640A8 (en) | Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof | |
| IL166592A0 (en) | Novel crystalline forms of gatifloxacin | |
| PL2181982T3 (pl) | Sposób wytwarzania chlorowodorku wenlafaksyny w formie I | |
| ITMI20020934A0 (it) | Processo per la sintesi di benazepril cloridrato | |
| FI20030747A0 (fi) | Toremifeenin kiteytysmenetelmä | |
| AU2003274608A1 (en) | Process for preparation of polymorphic form of sertraline hydrochloride | |
| ATE340161T1 (de) | Herstellung von quinapril hydrochlorid | |
| ITMI20020488A0 (it) | Forma cristallina di venlafaxina cloridrato | |
| SI1487840T1 (sl) | Kristalinična polimorfna oblika irinotekan hidroklorida | |
| HK1056545A (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
| IS7169A (is) | Kristölluð form valasýklóvírhýdróklóríðs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Reestablishment of rights (par. 72 patents act) | ||
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |